comparemela.com

Latest Breaking News On - Vistin pharma asa - Page 1 : comparemela.com

Vistin Pharma ASA: Fourth quarter and preliminary 2023

Oslo, Norway, 16th of February 2024 Vistin Pharma ASA (Vistin Pharma, OSE: VISTN) today announces the financial results for the fourth quarter of 2023. .

Alexander karlsenVistin pharmaNorwegian securities tradingOslo stock exchange vistnVistin pharma asa

Vistin Pharma ASA: Invitation to Q4 2023 conference call

Oslo, Norway, 9 February 2024 Vistin Pharma ASA will release its fourth quarter and preliminary 2023 results on Friday 16th of February 2024. Vistin.

Alexander karlsenVistin pharmaOslo stock exchange vistnVistin pharma asa

Key information relating to the cash dividend to be paid by

Dividend amount (per share): NOK 0.75 Declared currency: NOK Last day including right: 22 January 2024 Ex-date: 23 January 2024 Record date: 24.

Alexander karlsenNorwegian securities tradingOslo stock exchange vistnVistin pharma asa

Vistin Pharma ASA: Dividend of NOK 0 75 per share

Oslo, Norway, 11 January 2024 Norwegian pharmaceutical company Vistin Pharma ASA (“Vistin Pharma”) announced today that the Board has decided for a.

Vistin pharmaAlexander karlsenNorwegian securities tradingOslo stock exchange vistnVistin pharma asa

Vistin Pharma ASA: New CEO appointed

Oslo, Norway, 25th of October 2023 The Board of Directors of Vistin Pharma ASA has appointed Magnus Tolleshaug as the new CEO of Vistin Pharma from 1st.

Alexander karlsenKjell erik nordbyVistin pharmaMagnus tolleshaugTakeda pharmaceuticalsGlobal launch excellenceProduct lifecycle managementNorwegian securities tradingOslo stock exchange vistnVistin pharma asa

vimarsana © 2020. All Rights Reserved.